DJIA 16,654.77 369.26 2.27%
NASDAQ 4,812.71 115.17 2.45%
S&P 500 1,987.66 47.15 2.43%
market minute promo

INTREXON CORP (NYSE: XON)

44.82 0.53 (1.20%)

Quote as of


company name or ticker

Recent Quotes

XON $44.82 1.20%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $45.01
Previous Close $44.29
Daily Range $43.51 - $45.50
52-Week Range $16.13 - $69.45
Market Cap $4.9B
P/E Ratio -94.23
Dividend (Yield) $0.00 (0.4%)
Volume 1,067,113
Average Daily Volume 2,022,616
Current FY EPS -$0.32

Sector

Industry

INTREXON CORP (XON) Description

INTREXON CORP Website: http://www.dna.com/

News & Commentary Rss Feed

3 Biotech Stocks That Could Be Buyout Targets

Are these biotech stocks on the radar of bigger biotech and pharmaceutical companies? Though there's no way to know for certain, these companies certainly present attractive platforms for a potential acquirer.

First Week of April 2016 Options Trading For Intrexon (XON)

Perilous Reversal Stock: Intrexon (XON)

Health Care Sector Update for 08/21/2015: XON,MCUR,MBII

Time To Load Up On Biotechs?

After-Hours Trading Shows Intrexon (XON) Lagging

Intrexon Energy Partners and Dominion Enter Exclusive Agreement in Marcellus and Utica Basins to Com

Intrexon Energy Partners and Dominion Enter Exclusive Agreement in Marcellus and Utica Basins to Commercialize Novel Method for Natural Gas Bioconversion to Valuable Isobutanol

Intrexon (XON) Is Today's Dead Cat Bounce Stock

Why Ziopharm Oncology Shares Were Slammed

Ziopharm Oncology gets taken to the woodshed following the release of its second-quarter earnings results. Find out what went amiss.

Intrexon Second-Quarter Earnings: Rocket-Ship Growth and Acquisitions Continue

The synthetic biology leader set a new watermark for quarterly revenue in the second quarter and made a major acquisition. Here's what investors need to know.

See More XON News...